Tamara Pilishvili

17.0k total citations · 13 hit papers
90 papers, 11.8k citations indexed

About

Tamara Pilishvili is a scholar working on Epidemiology, Infectious Diseases and Health. According to data from OpenAlex, Tamara Pilishvili has authored 90 papers receiving a total of 11.8k indexed citations (citations by other indexed papers that have themselves been cited), including 67 papers in Epidemiology, 20 papers in Infectious Diseases and 20 papers in Health. Recurrent topics in Tamara Pilishvili's work include Pneumonia and Respiratory Infections (58 papers), Respiratory viral infections research (42 papers) and Vaccine Coverage and Hesitancy (20 papers). Tamara Pilishvili is often cited by papers focused on Pneumonia and Respiratory Infections (58 papers), Respiratory viral infections research (42 papers) and Vaccine Coverage and Hesitancy (20 papers). Tamara Pilishvili collaborates with scholars based in United States, United Kingdom and Canada. Tamara Pilishvili's co-authors include Ryan Gierke, Nancy M. Bennett, Cynthia G. Whitney, Tami H. Skoff, Monica M. Farley, Lee H. Harrison, Arthur Reingold, Matthew R. Moore, Stephanie R. Bialek and Michelle M. Hughes and has published in prestigious journals such as New England Journal of Medicine, JAMA and Nature Communications.

In The Last Decade

Tamara Pilishvili

90 papers receiving 11.3k citations

Hit Papers

Decline in Invasive Pneum... 2003 2026 2010 2018 2003 2020 2009 2020 2020 500 1000 1.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Decline in Invasive Pneumococcal Disease after the Introduction of Protein–Polysaccharide Conjugate Vaccine
    2003 1.7k citations Cynthia G. Whitney, Monica M. Farley et al. profile →
  2. Severe Outcomes Among Patients with Coronavirus Disease 2019 (COVID-19) — United States, February 12–March 16, 2020
    2020 1.6k citations Stephanie R. Bialek, Virginia B. Bowen et al. MMWR Morbidity and Mortality Weekly Report profile →
  3. Sustained Reductions in Invasive Pneumococcal Disease in the Era of Conjugate Vaccine
    2009 1.0k citations Tamara Pilishvili, Catherine Lexau et al. The Journal of Infectious Diseases profile →
  4. Coronavirus Disease 2019 in Children — United States, February 12–April 2, 2020
    2020 1.0k citations Stephanie R. Bialek, Ryan Gierke et al. MMWR Morbidity and Mortality Weekly Report profile →
  5. Preliminary Estimates of the Prevalence of Selected Underlying Health Conditions Among Patients with Coronavirus Disease 2019 — United States, February 12–March 28, 2020
    2020 992 citations Nancy A. Chow, Katherine E. Fleming-Dutra et al. MMWR Morbidity and Mortality Weekly Report profile →
  6. Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine Among Adults Aged ≥65 Years: Updated Recommendations of the Advisory Committee on Immunization Practices.
    2014 549 citations Sara Tomczyk, Nancy M. Bennett et al. PubMed profile →
  7. Surveillance of Vaccination Coverage Among Adult Populations — United States, 2014
    2016 375 citations Walter W. Williams, Peng-Jun Lu et al. PubMed profile →
  8. Surveillance of Vaccination Coverage among Adult Populations — United States, 2015
    2017 345 citations Walter W. Williams, Peng-Jun Lu et al. PubMed profile →
  9. Geographic Differences in COVID-19 Cases, Deaths, and Incidence — United States, February 12–April 7, 2020
    2020 343 citations Stephanie R. Bialek, Virginia B. Bowen et al. MMWR Morbidity and Mortality Weekly Report profile →
  10. Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine Among Adults Aged ≥65 Years: Updated Recommendations of the Advisory Committee on Immunization Practices
    2019 244 citations Ryan Gierke, Miwako Kobayashi et al. MMWR Morbidity and Mortality Weekly Report profile →
  11. Use of 15-Valent Pneumococcal Conjugate Vaccine and 20-Valent Pneumococcal Conjugate Vaccine Among U.S. Adults: Updated Recommendations of the Advisory Committee on Immunization Practices — United States, 2022
    2022 223 citations Miwako Kobayashi, Ryan Gierke et al. MMWR Morbidity and Mortality Weekly Report profile →
  12. Effectiveness of Pfizer-BioNTech and Moderna Vaccines in Preventing SARS-CoV-2 Infection Among Nursing Home Residents Before and During Widespread Circulation of the SARS-CoV-2 B.1.617.2 (Delta) Variant — National Healthcare Safety Network, March 1–August 1, 2021
    2021 189 citations Tamara Pilishvili, Gordana Derado et al. MMWR Morbidity and Mortality Weekly Report profile →
  13. Pneumococcal Vaccine for Adults Aged ≥19 Years: Recommendations of the Advisory Committee on Immunization Practices, United States, 2023
    2023 70 citations Miwako Kobayashi, Tamara Pilishvili et al. PubMed profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tamara Pilishvili United States 34 6.9k 3.1k 2.3k 1.4k 929 90 11.8k
Shamez Ladhani United Kingdom 61 7.3k 1.1× 3.6k 1.1× 4.4k 1.9× 1.1k 0.8× 625 0.7× 382 14.4k
Grace M. Lee United States 54 4.0k 0.6× 3.3k 1.1× 1.4k 0.6× 2.5k 1.8× 316 0.3× 205 9.9k
Jessica R. MacNeil United States 36 3.4k 0.5× 1.3k 0.4× 1.9k 0.8× 1.4k 1.0× 627 0.7× 80 6.5k
Tami H. Skoff United States 25 2.2k 0.3× 1.8k 0.6× 1.2k 0.5× 842 0.6× 486 0.5× 48 4.9k
Chris Robertson United Kingdom 55 2.6k 0.4× 2.5k 0.8× 642 0.3× 901 0.6× 2.0k 2.2× 272 11.7k
Timothy M. Uyeki United States 64 12.1k 1.8× 6.8k 2.2× 480 0.2× 1.4k 1.0× 471 0.5× 235 17.2k
Alicia M. Fry United States 69 12.6k 1.8× 4.8k 1.5× 495 0.2× 1.8k 1.3× 486 0.5× 250 16.9k
Amanda Cohn United States 30 2.1k 0.3× 1.3k 0.4× 1.2k 0.5× 994 0.7× 439 0.5× 84 4.5k
Carlos G. Grijalva United States 55 8.2k 1.2× 2.1k 0.7× 1.1k 0.5× 462 0.3× 227 0.2× 274 13.0k
Eric Weintraub United States 47 6.9k 1.0× 3.8k 1.2× 723 0.3× 3.0k 2.1× 162 0.2× 176 11.5k

Countries citing papers authored by Tamara Pilishvili

Since Specialization
Citations

This map shows the geographic impact of Tamara Pilishvili's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tamara Pilishvili with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tamara Pilishvili more than expected).

Fields of papers citing papers by Tamara Pilishvili

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tamara Pilishvili. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tamara Pilishvili. The network helps show where Tamara Pilishvili may publish in the future.

Co-authorship network of co-authors of Tamara Pilishvili

This figure shows the co-authorship network connecting the top 25 collaborators of Tamara Pilishvili. A scholar is included among the top collaborators of Tamara Pilishvili based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tamara Pilishvili. Tamara Pilishvili is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Childs, Lana, et al.. (2023). Systematic Review and Meta-Analysis of the Efficacy and Effectiveness of Pneumococcal Vaccines in Adults. Pathogens. 12(5). 732–732. 34 indexed citations
4.
5.
Fleming-Dutra, Katherine E., Allison Avrich Ciesla, Lauren E. Roper, et al.. (2023). Preliminary Estimates of Effectiveness of Monovalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection Among Children Aged 3–5 Years — Increasing Community Access to Testing Program, United States, July 2022–February 2023. MMWR Morbidity and Mortality Weekly Report. 72(7). 177–182. 11 indexed citations
6.
Mohr, Nicholas M., Ian D. Plumb, Karisa K. Harland, et al.. (2023). Presence of symptoms 6 weeks after COVID-19 among vaccinated and unvaccinated US healthcare personnel: a prospective cohort study. BMJ Open. 13(2). e063141–e063141. 17 indexed citations
7.
Gierke, Ryan, Monica M. Farley, William Schaffner, et al.. (2021). 1299. Epidemiology of Invasive Pneumococcal Disease (IPD) in the United States 2011-2019. Open Forum Infectious Diseases. 8(Supplement_1). S737–S738. 1 indexed citations
8.
Pilishvili, Tamara, Ryan Gierke, Monica M. Farley, et al.. (2020). 1470. Epidemiology of Invasive Pneumococcal Disease (IPD) Following 18 years of Pneumococcal Conjugate Vaccine (PCV) Use in the United States. Open Forum Infectious Diseases. 7(Supplement_1). S736–S737. 14 indexed citations
9.
Bialek, Stephanie R., Virginia B. Bowen, Nancy A. Chow, et al.. (2020). Geographic Differences in COVID-19 Cases, Deaths, and Incidence — United States, February 12–April 7, 2020. MMWR Morbidity and Mortality Weekly Report. 69(15). 465–471. 343 indexed citations breakdown →
10.
Beall, Bernard, Hollis Walker, Theresa Tran, et al.. (2020). Upsurge of Conjugate Vaccine Serotype 4 Invasive Pneumococcal Disease Clusters Among Adults Experiencing Homelessness in California, Colorado, and New Mexico. The Journal of Infectious Diseases. 223(7). 1241–1249. 26 indexed citations
11.
Pondo, Tracy, Lesley McGee, Monica M. Farley, et al.. (2019). Early Impact of 13-Valent Pneumococcal Conjugate Vaccine Use on Invasive Pneumococcal Disease Among Adults With and Without Underlying Medical Conditions—United States. Clinical Infectious Diseases. 70(12). 2484–2492. 51 indexed citations
12.
Pilishvili, Tamara, Ryan Gierke, Monica M. Farley, et al.. (2016). Direct and Indirect Impact of 13-Valent Pneumococcal Conjugate Vaccine (PCV13) Use on Invasive Pneumococcal Disease (IPD) Among Children and Adults. Open Forum Infectious Diseases. 3(suppl_1). 1 indexed citations
13.
Williams, Walter W., Peng-Jun Lu, Alissa O’Halloran, et al.. (2015). Vaccination coverage among adults, excluding influenza vaccination - United States, 2013.. PubMed. 64(4). 95–102. 153 indexed citations
14.
Tomczyk, Sara, Nancy M. Bennett, Charles Stoecker, et al.. (2014). Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine Among Adults Aged ≥65 Years: Updated Recommendations of the Advisory Committee on Immunization Practices.. PubMed. 63(37). 1069–1075. 549 indexed citations breakdown →
15.
Bennett, Nancy M., et al.. (2013). Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine Among Children Aged 6–18 Years with Immunocompromising Conditions: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morbidity and Mortality Weekly Report. 62(25). 521–524. 123 indexed citations
16.
Williams, Walter W., Peng-Jun Lu, Stacie M. Greby, et al.. (2013). Noninfluenza Vaccination Coverage Among Adults — United States, 2011. MMWR Morbidity and Mortality Weekly Report. 62(4). 66–72. 74 indexed citations
17.
Williams, Walter W., Peng-Jun Lu, Alissa O’Halloran, et al.. (2013). Noninfluenza Vaccination Coverage Among Adults—United States, 2011. JAMA. 309(10). 974–974. 186 indexed citations
18.
Murphy, Trudy V., et al.. (2012). Guidelines for vaccinating dialysis patients and patients with chronic kidney disease; summarized from recommendations of the Advisory Committee on Immunization Practices (ACIP). 18 indexed citations
19.
Pilishvili, Tamara, Catherine Lexau, Monica M. Farley, et al.. (2009). Sustained Reductions in Invasive Pneumococcal Disease in the Era of Conjugate Vaccine. The Journal of Infectious Diseases. 201(1). 32–41. 1025 indexed citations breakdown →
20.
Martinez, Joseph, et al.. (1999). A Flow Cytometric Opsonophagocytic Assay for Measurement of Functional Antibodies Elicited after Vaccination with the 23-Valent Pneumococcal Polysaccharide Vaccine. Clinical and Diagnostic Laboratory Immunology. 6(4). 581–586. 64 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shamez Ladhani Breakdown of academic impact, for papers by Grace M. Lee Breakdown of academic impact, for papers by Jessica R. MacNeil Breakdown of academic impact, for papers by Tami H. Skoff Breakdown of academic impact, for papers by Chris Robertson Breakdown of academic impact, for papers by Timothy M. Uyeki Breakdown of academic impact, for papers by Alicia M. Fry Breakdown of academic impact, for papers by Amanda Cohn Breakdown of academic impact, for papers by Carlos G. Grijalva Breakdown of academic impact, for papers by Eric Weintraub
Rankless by CCL
2026